COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 50: Line 50:
'''Gastrointestinal disorders and COVID-19'''
'''Gastrointestinal disorders and COVID-19'''
*'''[[User:Farima Kahe|Farima Kahe, M.D.]]'''
*'''[[User:Farima Kahe|Farima Kahe, M.D.]]'''
*[[User:Javaria Anwer|Javaria Anwer, M.B.B.S.]]
*[[User:TayyabaAli|Tayyaba Ali, M.D.]]
*[[User:TayyabaAli|Tayyaba Ali, M.D.]]
*  [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]
*  [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]]

Revision as of 21:38, 12 August 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

First Draft of the page

Constant Update of the Page

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members